20 0 1 1 1 1 (6)

Comments (6)

image

there are only two companies with approved CAR-T cell therapies at this time, and they do create a small sector with new issues and opportunities all their own.

   0   Reply (0)   Edit    Delete

    image

    there are other players in this game as well- companies that deal exclusively with the European market but are listed on the NYSE. It would be good to look at the market as a whole rather than driven by the few.

       0   Reply (0)   Edit    Delete

      image
      • Scott
      • ,  Contributor
      • 28 August 2018, 02:08 pm

      Very exciting developments.

         0   Reply (0)   Edit    Delete

        image
        • Jesse
        • ,  Contributor
        • 28 August 2018, 02:08 pm

        Gilead has a Zacks Rank #1 (Strong Buy).

           0   Reply (0)   Edit    Delete

          image
          • John R
          • ,  Contributor
          • 28 August 2018, 02:08 pm

          GILD\'s, KITE should be worth $20 billion by now.

             0   Reply (0)   Edit    Delete

            image
            • DoubleD
            • ,  Contributor
            • 28 August 2018, 02:08 pm

            GILD\'s problem, KITE\'s a lead balloon...

               0   Reply (0)   Edit    Delete

              Recent Updates

              •   
                Mar 6, 2019 11:15 PM

                DENTSPLY SIRONA Inc - Consumables Revenue

              •   
                Mar 6, 2019 11:15 PM

                DENTSPLY SIRONA Inc - Europe Revenue

              •   
                Mar 6, 2019 11:15 PM

                DENTSPLY SIRONA Inc - United States Revenue

              •   
                Mar 6, 2019 11:15 PM

                DENTSPLY SIRONA Inc - Rest of World Revenue

              •   
                Mar 6, 2019 11:15 PM

                DENTSPLY SIRONA Inc - Technologies and Equipment Total Net Sales ex. PM sales Revenue

              •   
                Mar 6, 2019 11:15 PM

                DENTSPLY SIRONA Inc - Technologies and Equipment Revenue